US$ 24.04
semaglutide 1.34 Judge Upholds FDA Deadline Ending
Description
Combining creatine with tirzepatide-based weight loss therapy requires careful consideration of kidney function and hydration status

Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.

The husband of a woman who died from complications of gastroparesis allegedly caused by Ozempic has filed a lawsuit against Novo Nordisk, the drug manufacturer

The @LaskerFDN 2024 Clinical Medical Research Award goes to GLP-1 scientists: Joel Habener, Svetlana Mojsov and @lotte_bjerre Perspective @NEJM by @DanielJDrucker